- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/06 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 237/06
Total number of patents in this class: 30
10-year publication summary
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10163 |
4 |
| Mwyngil Therapeutics, Inc. | 3 |
2 |
| Bristol-myers Squibb Company | 4756 |
1 |
| F. Hoffmann-La Roche AG | 7777 |
1 |
| BASF SE | 21339 |
1 |
| C4 Therapeutics, Inc. | 96 |
1 |
| Cytokinetics, Inc. | 252 |
1 |
| Eternity Bioscience Inc. | 15 |
1 |
| JNC Corporation | 1556 |
1 |
| JNC Petrochemical Corporation | 328 |
1 |
| Kowa Company, Ltd. | 1240 |
1 |
| Kyushu University, National University Corporation | 1741 |
1 |
| National University of Singapore | 2618 |
1 |
| Navinta LLC | 45 |
1 |
| Newron Pharmaceuticals S.p.A. | 57 |
1 |
| Shenyang Research Institute of Chemical Industry Co., Ltd. | 39 |
1 |
| Sinochem Corporation | 102 |
1 |
| Stahl International B.V. | 225 |
1 |
| Sumitomo Metal Mining Co., Ltd. | 2020 |
1 |
| Universite de Nantes | 335 |
1 |
| Other owners | 6 |